<DOC>
	<DOC>NCT01607190</DOC>
	<brief_summary>The purpose of this study is to validate a predictive model of diabetic retinopathy progression in patients with diabetes mellitus type 2 patients to clinically significant macular edema (CSME) needing treatment either photocoagulation or intravitreal injections (ITV) using non-invasive techniques.</brief_summary>
	<brief_title>Biomarkers of Diabetic Retinopathy Progression</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>Type 2 diabetes mellitus Age over 35 yearsold Nonproliferative diabetic retinopathy (Levels 20 to 35, according the ETDRS criteria) Best Corrected Visual Acuity &gt; 20/25 on the ETDRS chart Informed Consent Previous laser therapy Other retinal vascular disease Glaucoma Recent intraocular surgery (in the last 6 months) Inadequate ocular media and/ or pupil dilatation that do not permit good quality fundus photography (e.g. cataract) HbA1C &gt; 11 % at the Screening Subject that has a condition or that is in a situation which may put him/her at significant risk, may confound the study results or may interfere significantly with his/ her participation in the study.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>nonproliferative diabetic retinopathy</keyword>
</DOC>